Literature DB >> 11348370

Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes.

Rong Rong Huang1, Duan-Ren Wen, Jin Guo, Armando E. Giuliano, Mai Nguyen, Regina Offodile, Stacey Stern, Roderick Turner, Alistair J. Cochran.   

Abstract

Sentinel nodes (SNs), the nodes nearest a primary tumor on the direct lymphatic drainage path, are the site of earliest metastases, and in melanoma show striking immune modulation. We evaluated SNs from breast cancer patients for evidence of similar immune perturbation. The purpose of this study was to evaluate whether SNs from patients with breast cancer show the alterations in the histology and cytology of the paracortical areas seen in SNs from patients with melanoma. Formalin-fixed and paraffin-embedded sections from 32 SNs and 32 nonsentinel nodes (NSNs) from patients with breast cancer were evaluated. Sections were stained with hematoxylin and eosin and with antibodies to S-100 protein and HLA-DR, DQ, and DP to identify interdigitating dendritic cells (IDCs), and by an antibody to CD43RA to delineate T lymphocytes. By computerized image analysis we evaluated the distribution, frequency, immunophenotype, and activation status of IDCs and associated T lymphocytes in SNs and NSNs. Average areas occupied by S-100-positive dendritic cells (DCs) in SNs and NSNs were 0.13% and 19.98%, respectively, of total nodal area (p < 0.0001). The average density of S-100-positive IDCs in SNs was 11.00/mm2 and in NSNs was 257.88/mm2 (p < 0.0001). In SNs 43.55% of DCs (4.93/mm2) were nondendritic, 51.92% (5.69/mm2) had short dendrites, and 5.2% were mature with long dendrites (0.62/mm2). In SNs the ratio of immature to mature IDCs was 7.95:1. In NSNs, 8.09% of DCs (8.5/mm2) were nondendritic, 28.22% (67.46/mm2) had short dendrites, and 63.07% (145.96/mm2) were mature DCs with long dendrites. The ratio of immature to mature DCs in NSNs was 1:6.66. The average areas occupied by HLA class II-positive DCs in SNs and NSNs were 4.21% and 31.82%, respectively, of total nodal area. The frequency of coexpression of S-100 and HLA class II by immature IDCs without dendrites was 11.27% in SNs and 15.00% in NSNs. In both SNs and NSNs (p < 0.001) all mature S-100-positive IDCs with long dendrites expressed HLA class II. CD43RA-positive T lymphocytes occupied 20.06% of total nodal area in SNs and 63.57% in NSNs (p < 0.0001). The SNs from breast cancer patients are profoundly immune modulated with, by comparison to NSNs, markedly reduced paracortical areas, densities of paracortical DCs, frequency of S-100-positive IDCs coexpressing HLA class II, and a predominance of immature nondendritic and poorly dendritic DCs.

Entities:  

Year:  2000        PMID: 11348370     DOI: 10.1046/j.1524-4741.2000.98114.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  18 in total

1.  FOXP3 expression and nodal metastasis of breast cancer.

Authors:  Yesim Gökmen-Polar; Mangesh A Thorat; Payal Sojitra; Rashmil Saxena; Sunil Badve
Journal:  Cell Oncol (Dordr)       Date:  2013-08-31       Impact factor: 6.730

Review 2.  The lymph node pre-metastatic niche.

Authors:  Jonathan P Sleeman
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

Review 3.  The lymph node microenvironment and its role in the progression of metastatic cancer.

Authors:  Ethel R Pereira; Dennis Jones; Keehoon Jung; Timothy P Padera
Journal:  Semin Cell Dev Biol       Date:  2015-01-22       Impact factor: 7.727

4.  Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.

Authors:  Barbara G Molenkamp; Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Wim Vos; Pepijn G J T B Wijnands; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status.

Authors:  Raavi Gupta; James S Babb; Baljit Singh; Luis Chiriboga; Leonard Liebes; Sylvia Adams; Sandra Demaria
Journal:  Cancer Invest       Date:  2011-07       Impact factor: 2.176

Review 6.  Mechanism of lymph node metastasis in prostate cancer.

Authors:  Kaustubh Datta; Michael Muders; Heyu Zhang; Donald J Tindall
Journal:  Future Oncol       Date:  2010-05       Impact factor: 3.404

7.  Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells.

Authors:  Aaron Scott Mansfield; Paivi Heikkila; Karl von Smitten; Jukka Vakkila; Marjut Leidenius
Journal:  Virchows Arch       Date:  2011-09-06       Impact factor: 4.064

8.  Infiltration of antitumor immunocytes into the sentinel node in gastric cancer.

Authors:  Sumiya Ishigami; Shoji Natsugoe; Yoshikazu Uenosono; Yoichi Hata; Aikihiro Nakajo; Futoshi Miyazono; Masataka Matsumoto; Shuichi Hokita; Takashi Aikou
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

9.  Tc-99m diphosphonate as a potential radiotracer to detect sentinel lymph nodes in patients with breast cancer.

Authors:  You-Jung Yang; Sung-Jig Lim; Jeong-Yoon Song
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

Review 10.  Detection of cancer metastasis: past, present and future.

Authors:  Catherine Alix-Panabieres; Anthony Magliocco; Luis Enrique Cortes-Hernandez; Zahra Eslami-S; Daniel Franklin; Jane L Messina
Journal:  Clin Exp Metastasis       Date:  2021-05-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.